Dr. Mike Yeadon - Unlocked
First published at 15:32 UTC on November 24th, 2020.
MORE
Category | Education |
Sensitivity | Normal - Content that is suitable for ages 16 and over |
The owner has disabled discussion of this video.
An error has occurred whilst processing your request!
If the issue persists, then please contact us at [email protected].
This advertisement has been selected by the video's creator, .
This advertisement has been selected by BitChute. Displaying these adverts helps support the growth and sustainability of the platform.
This advertisement has been sourced through third-party advertising partners on behalf of BitChute. Displaying these adverts helps support the growth and sustainability of the platform.
For more information on how BitChute processes your data, and to learn how to opt out of advertising, see our Privacy Policy.
Click to copy, then share by pasting into your messages, comments, social media posts and websites.
Click to copy, then add into your webpages so users can view and engage with this video from your site.
We also accept reports via email. Please see the Guidelines Enforcement Process for instructions on how to make a request via email.
We will investigate and take the appropriate action.
Dr. Michael Yeadon, Former VP of Pfizer, is an Allergy & Respiratory Therapeutic Area expert with 23 years in the pharmaceutical industry. He trained as a biochemist and pharmacologist, obtaining his PhD from the University of Surrey (UK) in 1988.
Dr. Yeadon then worked at the Wellcome Research Labs with Salvador Moncada with a research focus on airway hyper-responsiveness and effects of pollutants including ozone and working in drug discovery of 5-LO, COX, PAF, NO and lung inflammation. With colleagues, he was the first to detect exhaled NO in animals and later to induce NOS in lung via allergic triggers.
Joining Pfizer in 1995, he was responsible for the growth and portfolio delivery of the Allergy & Respiratory pipeline within the company. He was responsible for target selection and the progress into humans of new molecules, leading teams of up to 200 staff across all disciplines and won an Achievement Award for productivity in 2008.
Under his leadership the research unit invented oral and inhaled NCEs which delivered multiple positive clinical proofs of concept in asthma, allergic rhinitis and COPD. He led productive collaborations such as with Rigel Pharmaceuticals (SYK inhibitors) and was involved in the licensing of Spiriva and acquisition of the Meridica (inhaler device) company.
Dr. Yeadon has published over 40 original research articles and now consults and partners with a number of biotechnology companies. Before working with Apellis, Dr. Yeadon was VP and Chief Scientific Officer (Allergy & Respiratory Research) with Pfizer.
Category | Education |
Sensitivity | Normal - Content that is suitable for ages 16 and over |
3 years, 2 months ago
Egon Olsen hat immer gesagt, ich habe einen Plan.... und am Ende saß er im Knast 😂
3 years, 2 months ago
Robert Franz: Eine Revolution ist fällig, aber mit wem?
3 years, 2 months ago
Post - Covid Ära: „Das goldene Zeitalter?“
3 years, 2 months ago
MARKmobil Aktuell - Elektrogeld trifft Alltag
3 years, 2 months ago
Putin ist schuld! Wer ist Joe Biden?
3 years, 2 months ago
To dismiss this warning and continue to watch the video please click on the button below.
Note - Autoplay has been disabled for this video.